W
WAVEMAN · COMPANY
MRMD · Marimed Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

MRMD

MARIMED INC.
PHARMA & BIOTECH · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · CIK 0001522767
C-SUITE BUYING · 1☆ WATCH
INSIDER NET · 180D
$7.8K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
0
13F, latest reported quarter
REVENUE GROWTH
+1.3%
XBRL, annual
NET MARGIN
-9.1%
CONVERSIONS · 180D
20
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$7.8K over 180 days
+$7.8K of it by a 10%+ holder
more than 67% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
fewer than five institutions report holding it
REVENUE
+1.3% year over year
below 51% of Pharma & Biotech
MARGIN
-9.1% net margin
more than 57% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
<0.1% of shares outstanding short · 1.0 days to cover · settled 2026-07-31
the lowest in Pharma & Biotech
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -55.6%
-55.6%12M
-65%-43%-22%+0%2025-092025-102025-122026-032026-052026-072026-09 2025-12-12 · Shaw Timothy bought $5.0K2026-05-20 · Levine Jon R bought $3.2K2026-05-22 · Levine Jon R bought $3.0K2026-05-22 · Levine Jon R bought $1.4K2026-05-22 · Levine Jon R bought $240
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders are net buyers of their own stock.
The record shows a net $7.8K bought by insiders over 180 days. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, MARIMED INC. insiders bought a net $7.8K of stock across 13 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Levine Jon R
President and CEO
BUY
2026-05-22
37,000.0
$3.0K
Levine Jon R
President and CEO
BUY
2026-05-22
3,000.0
$240
Levine Jon R
President and CEO
BUY
2026-05-22
20,000.0
$1.4K
Levine Jon R
President and CEO
BUY
2026-05-20
40,000.0
$3.2K
Shaw Timothy
Chief Operating Officer
BUY
2025-12-12
45,455.0
$5.0K
13 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 8 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Canton Hathaway, LLC
645,100.0 sh
$45.2K
Game Plan Financial Advisors, LLC
100.0 sh
$7
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$159.8M$157.7M$148.6M$134.0M
GROSS PROFIT$57.9M$62.6M$65.9M$64.0M
OPERATING INCOME$-2.8M$2.6M$14.4M$20.4M
NET INCOME$-14.5M$-12.5M$-16.0M$13.5M
EPS (DILUTED)-0.04-0.03-0.040.04
OPERATING CASH FLOW$7.7M$6.8M$7.9M$7.3M
CASH$7.3M$14.6M$9.7M
LONG-TERM DEBT$76.0M$78.2M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →